Overview
Jan Hrabeta practices in Prague, Czech Republic. Hrabeta is rated as an Advanced expert by MediFind in the treatment of Neuroblastoma. Their top areas of expertise are Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Gliomatosis Cerebri, and Retinoblastoma.
Their clinical research consists of co-authoring 40 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 18 articles in the study of Neuroblastoma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Embryonal Tumor with Multilayered Rosettes
- NeuroblastomaHrabeta isAdvanced. Learn about Neuroblastoma.
- Experienced
- Brain TumorHrabeta isExperienced. Learn about Brain Tumor.
- Gliomatosis CerebriHrabeta isExperienced. Learn about Gliomatosis Cerebri.
- RetinoblastomaHrabeta isExperienced. Learn about Retinoblastoma.